Page last updated: 2024-08-25

dienogest and Cancer of Endometrium

dienogest has been researched along with Cancer of Endometrium in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Honda, R; Katabuchi, H; Ohba, T; Saito, F; Suzuki, A; Tashiro, H; Yamaguchi, M1
Aoki, D; Banno, K; Kisu, I; Kobayashi, Y; Masuda, K; Nomura, H; Susumu, N; Tsuji, K; Ueki, A; Yamagami, W; Yanokura, M1
Aoki, D; Katsuki, Y; Nozawa, S; Shibutani, Y1
Skouby, SO1

Reviews

2 review(s) available for dienogest and Cancer of Endometrium

ArticleYear
Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
    International journal of oncology, 2012, Volume: 40, Issue:6

    Topics: Animals; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Nandrolone; Progestins

2012
The rationale for a wider range of progestogens.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3 Suppl 2

    Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome

2000

Other Studies

2 other study(ies) available for dienogest and Cancer of Endometrium

ArticleYear
Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:5

    Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Endometrial Neoplasms; Female; Medroxyprogesterone Acetate; Mice; Nandrolone; Progestins; Treatment Outcome

2016
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Cancer, 1997, Jan-01, Volume: 79, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Mice; Mice, SCID; Nandrolone; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

1997